New recommendations for workplace chemical risk assessment published

The Permanent Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area of the DFG has now published the English version of its latest research-based recommendations on the risk assessment of substances used at the workplace.

Japan approves BMS’ Abecma for multiple myeloma treatment

Share this article Bristol-Myers Squibb’s Abecma is a BCMA-directed chimeric antigen receptor T cell immunotherapy. Credit: Dennis Diatel / Shutterstock.com. Japan has granted manufacturing and

December 7, 2023

USPSTF Backs New Options for HIV Prevention; Occupational Radiation Exposure

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

August 27, 2023

Breas Medical flags risk of formaldehyde exposure in ventilators

Dive Brief: Breas Medical started a correction of more than 8,000 ventilators after identifying a risk of formaldehyde exposure, the company said Friday. The notice,

August 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.